Location: Greater Boston Region (Travel to China required a few times annually)
Company Stage: Seed-stage biotech specializing in mRNA-based therapies with teams in both Boston, USA, and Guangdong, China.
About Us
Our trans-Pacific biotech startup is breaking new ground in targeted mRNA delivery technology. We’re a dynamic, collaborative team working across Boston, USA, and Guangdong, China, united by a shared vision of advancing mRNA therapeutics to improve lives worldwide. As we expand our research and development (R&D) efforts, securing strategic funding and partnerships is critical to accelerating our mission.
We are seeking a Chief Investment & Business Officer (CIBO) to lead our capital-raising efforts, investor relations, and financial strategy. This high-impact role is ideal for a biotech fundraising and investment leader who has successfully secured venture capital, private equity financing, and strategic investment partnerships.
The Role
This is more than just a leadership role—it’s an opportunity to steer innovation on a global stage. As CIBO, you’ll drive strategy, bridge cultural and operational gaps between our U.S. and China teams, and spearhead the next phase of our mRNA platform’s development. From aligning R&D milestones to building investor trust, you’ll be at the heart of our mission to deliver breakthrough therapies.
This is a mission-critical role at the intersection of biotech financing and investment strategy. As CIBO, you will drive capital-raising initiatives, shape investor strategy, and position the company for long-term financial success. You will be responsible for fundraising, investor engagement, capital structuring, and financial planning while ensuring alignment between scientific innovation, financing needs, and business growth.
What You’ll Do
Fundraising & Investment Strategy (Primary Focus)
✅ Develop & execute capital-raising strategies to secure funding for R&D and clinical programs.
✅ Lead investor relations, actively engaging VC firms, private equity, institutional investors, and corporate partners.
✅ Identify & cultivate relationships with potential investors, driving financial negotiations and funding agreements.
✅ Structure financing rounds, including private equity stake financing, Series A/B funding, and IPO preparation.
✅ Position the company for valuation growth, ensuring capital allocation aligns with corporate objectives.
Business Development & Strategic Partnerships (Secondary Focus)
✅ Support the CEO & BD teams in identifying and negotiating strategic collaborations, licensing deals, and co-development opportunities.
✅ Oversee market expansion strategies, ensuring that investment decisions align with our long-term commercialization plan.
✅ Leverage investor networks to secure industry alliances and access strategic funding sources.
Corporate & Financial Strategy
✅ Work closely with the Board to align financial planning with corporate growth.
✅ Conduct risk assessments, financial modeling, and ROI-driven decision-making.
✅ Ensure capital efficiency & regulatory compliance for biotech financing and investment structures.
✅ Advise leadership on investor expectations, financial milestones, and long-term funding goals.
Other focus areas include, but are not limited to:
• Lead Strategically: Shape and execute a bold vision for advancing our mRNA delivery platform.
• Fundraise Effectively: Build relationships with U.S. and global investors to secure critical resources for growth.
• Collaborate Globally: Unite and inspire our cross-regional teams, fostering seamless communication across time zones and cultures.
• Drive Science Forward: Partner with R&D teams to achieve technical milestones and regulatory readiness.
• Build Partnerships: Develop collaborations with research institutions and biopharma partners to accelerate commercialization.
• Ensure Compliance: Guide teams to meet regulatory standards in both U.S. and global markets.
• Grow the Team: Cultivate a diverse, high-performing team with a shared passion for innovation.
• Stay Ahead: Monitor industry trends and keep our platform competitive on the global stage.
What You Bring
Minimum Qualifications:
✅ 10+ years in biotech venture capital, investment banking, private equity, or corporate finance.
✅ Proven track record in securing VC/private equity financing and leading biotech fundraising efforts.
✅ Strong investor network with biotech VCs, institutional funds, and life sciences investors.
✅ Demonstrated ability to lead capital-raising initiatives, including Series A/B financing.
✅ Business acumen with a deep understanding of biotech R&D funding models and investment strategies.
✅ Experience working with cross-regional teams in the U.S. and China.
Preferred Qualifications:
✅ Proficiency in Mandarin or extensive experience in U.S.-East Asia investment ecosystems.
✅ Success in guiding biotech startups from early-stage funding to IPO readiness.
✅ Existing relationships with U.S. and global biotech investors.
✅ Strategic mindset with expertise in scaling biotech investment portfolios.
Why Join Us?
💰 Drive multi-million-dollar biotech fundraising & investment deals.
🚀 Work at the forefront of mRNA drug delivery & cutting-edge biotech.
🌍 Engage with leading investors, research teams, and BD executives worldwide.
📈 Be part of a high-growth biotech startup with a cross-border innovation model.
What We Offer:
💵 Competitive base salary + performance-based bonus + equity options
🏥 Comprehensive health, dental, and vision benefits
📅 Generous paid time off (vacation, sick leave, company holidays)
💼 401(k) retirement plan with company match
🌎 Professional development & travel opportunities (U.S. & China)
The Process:
1️⃣ Interview meeting with BD, Ops & BU Head.
2️⃣ Interview meeting with Board Members.
This is a unique opportunity to lead biotech investment strategy at a breakthrough mRNA startup. Are you ready to drive fundraising, shape biotech financing, and build a high-growth future?
This is your chance to lead at the intersection of science and strategy, bridging continents and ideas to bring groundbreaking therapies to market. Are you ready to take on the challenge?
#LI-NW1
If an employer mentions a salary or salary range on their job, we display it as an "Employer Estimate". If a job has no salary data, Rise displays an estimate if available.
We are thrilled to announce an extraordinary opportunity at our seed-stage biotech company based in Boston, MA, where we specialize in cutting-edge mRNA-based therapies. As the Chief Investment & Business Officer (CIBO), you will play a pivotal role in driving our capital-raising efforts and shaping our financial strategy that will propel our mission of delivering breakthrough therapies to improve lives worldwide. Your expertise will be instrumental as you lead fundraising initiatives, engage with venture capital firms and investors, and cultivate relationships that align financial growth with our innovative R&D goals. In this role, you’ll not only bridge the cultural and operational landscapes of our teams across Boston and Guangdong, China, but also steer the direction of our financial planning to ensure that we remain at the forefront of biotech advancement. Joining our dynamic team means that you will be at the heart of strategic negotiations, partnering with globally recognized investors, and collaborating with passionate researchers committed to making a genuine impact. Your leadership in structuring financing rounds, as well as guiding our teams through compliance and regulatory standards, will drive our company's long-term success. This isn't just a job; it’s your chance to lead a transformative journey across continents, to break barriers and innovate within the biotechnology field. If you’re ready to make meaningful contributions in a fast-paced, mission-driven environment, we invite you to explore this exciting role further!
With over 20 years development in the IVD industry, Fapon has become the largest IVD raw materials provider in China and a leading supplier of total solution of "reagents + core materials" in the world. The fast growth of the company has offered F...
3 jobsSubscribe to Rise newsletter